Figure 4: Subcutaneous administration of ODSH (25 mg/kg every 12 h; Days 1-2 and 17.5 mg/kg every 12 h; Days 3-7) did not improve (A) spleen mass or (B) bone marrow cell depletion after whole-body ionizing irradiation alone (RI) or when combined with skin burn injury (CI) in female B6D2F1/J mice. N=4-8 per group. Vehicle and ODSH groups received additional topical gentamicin (0.1% cream; Days 1-10) and oral levofloxacin (100 mg/kg; Days 3-16) treatment. Data are expressed as mean ± SEM; *p<0.05 compared to sham and burn groups only.